Biotech
Prodex, Inc (NASDAQ: PDEX)
Interview update with Rick Van Kirk, CEO […]
Biotech
Biotech
SeaStar Medical Holding Corp (NASDAQ: ICU)
Interview with Eric Schlorff, CEO and President […]
Biotech
Prodex, Inc (NASDAQ: PDEX)
Interview with Rick Van Kirk, CEO […]
Biotech
Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe
Generex Biotechnology Corporation is an integrated healthcare holding company with end‐to‐end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. […]
Biotech
Eastgate Biotech Corp (OTC: ETBI) Management Interview
Interview with COO Bill Abajian […]
Biotech
Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals
Interview with Dwight Egan, CEO […]
Biotech
Generex Biotechnology Announces Interview with CEO Joe Moscato
MIRAMAR, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (OTCQB:GNBT) today announced that Joe Moscato, the company’s President & Chief Executive Officer conducted an interview with the Wall Street Analyzer, which is available […]
Biotech
EastGate Biotech Files Application to Initiate Phase III Clinical Trial for Insugin
Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan […]
Biotech
EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 diabetes patients
Multi-Center Phase III trial planned for 2019
[…]
Biotech
Anna Gluskin, CEO of Eastgate BioTech (OTC: ETBI) discusses positive results and how they are ready to take the Insulin market by storm.
“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]